1-16125329-C-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM2PP3PP5_Very_Strong
The NM_004431.5(EPHA2):c.2826-9G>A variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: not found (cov: 25)
Consequence
EPHA2
NM_004431.5 splice_polypyrimidine_tract, intron
NM_004431.5 splice_polypyrimidine_tract, intron
Scores
2
Splicing: ADA: 0.9984
2
Clinical Significance
Conservation
PhyloP100: -1.43
Genes affected
EPHA2 (HGNC:3386): (EPH receptor A2) This gene belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. This gene encodes a protein that binds ephrin-A ligands. Mutations in this gene are the cause of certain genetically-related cataract disorders.[provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 11 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
Splicing scoreres supports a deletorius effect: Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF, max_spliceai. No scorers claiming Uncertain. No scorers claiming Benign.
PP5
Variant 1-16125329-C-T is Pathogenic according to our data. Variant chr1-16125329-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 280146.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-16125329-C-T is described in Lovd as [Likely_pathogenic]. Variant chr1-16125329-C-T is described in Lovd as [Likely_pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EPHA2 | NM_004431.5 | c.2826-9G>A | splice_polypyrimidine_tract_variant, intron_variant | ENST00000358432.8 | NP_004422.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EPHA2 | ENST00000358432.8 | c.2826-9G>A | splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_004431.5 | ENSP00000351209 | P1 |
Frequencies
GnomAD3 genomes Cov.: 25
GnomAD3 genomes
Cov.:
25
GnomAD4 exome Cov.: 33
GnomAD4 exome
Cov.:
33
GnomAD4 genome Cov.: 25
GnomAD4 genome
Cov.:
25
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Cataract 6 multiple types Pathogenic:3
Likely pathogenic, no assertion criteria provided | clinical testing | Genomics England Pilot Project, Genomics England | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 13, 2020 | This sequence change falls in intron 16 of the EPHA2 gene. It does not directly change the encoded amino acid sequence of the EPHA2 protein. This variant is not present in population databases (ExAC no frequency). For these reasons, this variant has been classified as Pathogenic. Experimental studies using a mini-gene assay reported that this variant causes  aberrant splicing resulting in a protein product that extends the carboxy-terminal SAM domain by 71 amino acid residues (PMID: 19306328). This extension alters EPHA2 protein solubility, intracellular localization, protein-protein interaction, and the ability to induce the phosphorylation of Akt kinase (PMID: 19306328, 22570727, 26900323). This variant has been reported to segregate with autosomal dominant congenital cataracts in several families (PMID: 19306328, 24014202). ClinVar contains an entry for this variant (Variation ID: 280146). - |
Pathogenic, no assertion criteria provided | literature only | OMIM | May 01, 2009 | - - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 29, 2024 | The c.2826-9G>A intronic alteration results from a G to A substitution 9 nucleotides before coding exon 17 in the EPHA2 gene. for autosomal dominant EPHA2-related cataract; however, its clinical significance for autosomal recessive EPHA2-related cataract is uncertain. This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This variant has been found to segregate with affected individuals in multiple families with autosomal dominant congenital cataract (Zhang, 2009; Dave, 2013; Astiazarán, 2018; Berry, 2018). This nucleotide position is poorly conserved in available vertebrate species. A minigene assay confirmed that c.2826-9G>A results in aberrant splicing (Zhang, 2009). In silico splice site analysis predicts that this alteration will weaken the native splice acceptor site and will result in the creation or strengthening of a novel splice acceptor site. Based on the available evidence, this alteration is classified as pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Dec 16, 2021 | Non-canonical splice site variant demonstrated to result in loss-of-function (Zhang et al, 2009); Not observed at significant frequency in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 30450742, 29039721, 33671840, 22570727, 26900323, 19306328, 24014202) - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
dbscSNV1_RF
Pathogenic
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AG_spliceai
Position offset: -2
DS_AL_spliceai
Position offset: -9
Find out detailed SpliceAI scores and Pangolin per-transcript scores at